New and updated publications from the Congressional Research Service that Congress has withheld from online public access include the following.
Staff Pay Levels for Selected Positions in House Member Offices, 2009-2013, November 3, 2014
Staff Pay Levels for Selected Positions in Senators’ Offices, FY2009-FY2013, November 3, 2014
Congressional Action on FY2015 Appropriations Measures, November 5, 2014
The G-20 Summit: Brisbane, November 15-16, 2014, CRS Insights, November 5, 2014
Treating Ebola Patients in the United States: Health Care Delivery Implications, CRS Insights, November 4, 2014
EPA’s Clean Power Plan Proposal: Are the Emission Rate Targets Front-Loaded?, CRS Insights, November 3, 2014
How Will the Federal Reserve “Normalize” Monetary Policy After QE?, CRS Insights, October 30, 2014
Federal Taxation of Marijuana Sellers, CRS Legal Sidebar, November 6, 2014
Voter Identification Requirements: Background and Legal Issues, November 3, 2014
Qatar: Background and U.S. Relations, November 4, 2014
Immigration Legislation and Issues in the 113th Congress, November 4, 2014
Border Security: Immigration Inspections at Ports of Entry, October 31, 2014
Renewable Energy R&D Funding History: A Comparison with Funding for Nuclear Energy, Fossil Energy, and Energy Efficiency R&D, October 10, 2014
Using the NIST as an example, the Radiation Physics Building (still without the funding to complete its renovation) is crucial to national security and the medical community. If it were to go down (or away), every medical device in the United States that uses radiation would be decertified within 6 months, creating a significant single point of failure that cannot be quickly mitigated.
The federal government can support more proactive, efficient, and cost-effective resiliency planning by certifying predictive models to validate and publicly indicate their quality.
We need a new agency that specializes in uncovering funding opportunities that were overlooked elsewhere. Judging from the history of scientific breakthroughs, the benefits could be quite substantial.
The cost of inaction is not merely economic; it is measured in preventable illness, deaths and diminished livelihoods.